Charly Ryan Good
University of Pennsylvania Health System · 71 works · 1,425 citations · h-index 12
Top works
- An NK-like CAR T cell transition in CAR T cell dysfunction
- Impaired Death Receptor Signaling in Leukemia Causes Antigen-Independent Resistance by Inducing CAR T-cell Dysfunction
- Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cells
- TET1-Mediated Hypomethylation Activates Oncogenic Signaling in Triple-Negative Breast Cancer
- p53 mediates target gene association with nuclear speckles for amplified RNA expression
- Reverse Transcriptase Inhibition Disrupts Repeat Element Life Cycle in Colorectal Cancer.
- A novel isoform of TET1 that lacks a CXXC domain is overexpressed in cancer
- Reverse Transcriptase Inhibition Disrupts Repeat Element Life Cycle in Colorectal Cancer
- TOX2 coordinates with TET2 to positively regulate central memory differentiation in human CAR T cells
- Demethylator phenotypes in acute myeloid leukemia
- Clinical and molecular dissection of CAR T cell resistance in pancreatic cancer
- Comparison of genotoxic versus nongenotoxic stabilization of p53 provides insight into parallel stress-responsive transcriptional networks
- Histone acetylation in an Alzheimer’s disease cell model promotes homeostatic amyloid-reducing pathways
- Deciphering the role of histone modifications in memory and exhausted CD8 T cells
- Impaired tumor death receptor signaling drives resistance to CAR T cell therapy
- Abstract 2659: A novel isoform of TET1 that lacks a CXXC domain is overexpressed in cancer
- Abstract 60: Induction of T cell dysfunction and NK-like T cell differentiation in vitro and in patients after CAR T cell treatment
- 237 Enhancing mesothelin-directed CAR T cell therapy for unresectable or metastatic pancreatic adenocarcinoma
- Chromatin repression by PRC2 results in reduced gene expression driving key features of CD8 T cell exhaustion
- Supplementary Figures S1-6, Supplementary Tables S1-3, Supplementary methods from TET1-Mediated Hypomethylation Activates Oncogenic Signaling in Triple-Negative Breast Cancer